DNA Methylation Market Size to Hit US$ 2.93 Billion by 2028 | CAGR of 14.60%

According to the latest report by IMARC Group "DNA Methylation Market: Global Industry Size, Share, Trends, Growth Rate, Research Report, Opportunity and Forecast 2023-2028". The global DNA methylation market size reached US$ 1.30 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.93 Billion by 2028, exhibiting a growth rate (CAGR) of 14.60% during 2023-2028. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

Deoxyribonucleic acid (DNA) methylation is a cellular mechanism for controlling gene expression, an epigenetic process. It involves adding a methyl group (CH3) to the 5' position of the cytosine, followed by guanine in the DNA sequence. It is utilized in plants to manipulate gene expression and develop new plant varieties with improved yield, disease resistance, and tolerance to environmental stresses. At present, DNA methylation finds extensive applications in laboratories for studying biological systems and evolving different species due to its versatility.

Request for a free sample copy of this report: https://www.imarcgroup.com/dna-methylation-market/requestsample

DNA Methylation Market Trends:

The global DNA methylation market is primarily driven by the rising incidence of chronic diseases, including cancer, diabetes, hypertension, arthritis, Alzheimer's disease, and cardiovascular diseases (CVDs). Moreover, the surging adoption of DNA methylation as a biomarker for identifying epigenetic changes associated with certain conditions, as it allows early detection of diseases, improves patient outcomes and reduces healthcare costs, is positively influencing the market growth. Additionally, expanding geriatric population, which is more prone to developing chronic conditions, has catalyzed the market growth. Furthermore, the rising use of DNA methylation as a non-invasive diagnostic tool, which helps enhance patient comfort and reduce the risk of complications, is contributing to the market growth. Other factors, including ongoing research and development (R&D) activities, increasing utilization of DNA methylation in developing new plant varieties, and rising healthcare expenditures, are also anticipated to propel the market growth.

Report Segmentation:

The report has segmented the market into the following categories:

Product Insights:

Consumables
Kits and Reagents
Enzymes
Instrument and Software

Technology Insights:

Polymerase Chain Reaction (PCR)
Microarray
Sequencing
Others

Application Insights:

Gene Therapy
Clinical Research
Diagnostics
Others

End User Insights:

Hospital and Diagnostic Laboratories
Pharmaceutical and Biotechnology Companies
Research and Academia

Market Breakup by Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

Competitive Landscape:

Abcam plc.
Active Motif Inc.
Diagenode S.A. (Hologic Inc.)
EpiGentek Group Inc.
Illumina Inc.
Merck KGaA
New England Biolabs Inc.
PerkinElmer Inc., Qiagen N.V.
Thermo-Fisher Scientific Inc.
Zymo Research Corporation

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/dna-methylation-market

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Contact US

IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.